Testing Beneficial Therapy in Human Cirrhosis Using Animal Models of Cirrhosis

Author： Hoefs John   Morgan Timothy   Ilagan Bernard  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.4, 2011-04, pp. : 929-930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 598-607

Karger

Access to resources Recommend Favorite

Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models

By Ueno Yoshiyuki   Moritoki Yuki   Shimosegawa Tooru   Gershwin M. Eric  

Journal of Gastroenterology, Vol. 42, Iss. 3, 2007-03 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 613-623

Karger

Access to resources Recommend Favorite

Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 608-612

Karger

Access to resources Recommend Favorite

Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis

By  

Digestion, Vol. 83, Iss. 4, 2011-02 ,pp. : 275-282

Karger

Access to resources Recommend Favorite